| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 07/11/2006 | CA2198210C Non self-inactivating, expression targeted retroviral vectors |
| 07/06/2006 | WO2006071563A2 Non-tumorigenic mdck cell line for propagating viruses |
| 07/06/2006 | WO2006070011A1 Methods to obtain recombinant proteins with increased sialylation from cells that express adenovirus e1a protein, and proteins obtained thereby |
| 07/06/2006 | WO2006069505A1 The complex granule of hepatitis b surface antigen containing front surface antigen s1 , s2 and s immune determinants. |
| 07/06/2006 | WO2006069413A2 Method for isolating cells and viruses |
| 07/06/2006 | WO2006046963A9 Generation of virus-like particles and use as panfilovirus vaccine |
| 07/06/2006 | WO2006031996A3 Targeting viruses using a modified sindbis glycoprotein |
| 07/06/2006 | WO2005049639A3 Compositions and methods for protein isolation |
| 07/06/2006 | WO2003072718A3 In situ induced antigen technology (isiat) for identification of polynucleotides expressed during infection or colonization |
| 07/06/2006 | US20060148074 Serum-free mammalian cell culture medium, and uses thereof |
| 07/06/2006 | US20060147950 Precursor conversion screening method |
| 07/06/2006 | US20060147469 Recombinant hepatitis a virus antigens obtained in plant cells |
| 07/06/2006 | US20060147464 immunogens; immunololgy; for production of vaccines; able to induce antiserum having neutralizing antibody; neutralization assay; Mareks Disease virus, infectious bronchitis virus, Newcastle disease virus, egg drop syndrome virus, turkey rhinotracheitis virus, or reovirus |
| 07/06/2006 | US20060147419 Recombinant vaccine viruses expressing il-15 and methods of using the same |
| 07/06/2006 | US20060147418 Recombinant double stranded rna phages and uses thereof |
| 07/06/2006 | CA2592141A1 Virus preparations and methods |
| 07/06/2006 | CA2592100A1 Methods to obtain recombinant proteins with increased sialylation from cells that express adenovirus e1a protein, and proteins obtained thereby |
| 07/05/2006 | EP1676586A1 Method of separating rotavirus variants and live attenuated rotavirus vaccine |
| 07/05/2006 | EP1675942A2 Immunogenic composition and method of developing a vaccine based on cyclophilin a binding site |
| 07/05/2006 | EP1675612A2 Immunogenic composition and method of developing a vaccine based on factor h binding sites |
| 07/05/2006 | EP1155120B1 Method for obtaining a purified viral preparation |
| 07/05/2006 | EP0778889B1 Recombinant adenovirus comprising a chimeric penton base protein |
| 07/05/2006 | EP0695360B1 Defective recombinant adenoviruses for gene therapy of tumours |
| 07/05/2006 | CN1798845A 黄病毒复制子包装系统 Flavivirus replicon packaging systems |
| 07/05/2006 | CN1796565A Recombined virus for expressing spike protein of SARS coronavirus and preparation method |
| 07/05/2006 | CN1796564A Recombined virus for expressing nucleoprotein of SARS coronavirus and preparation method |
| 07/05/2006 | CN1796546A Optimal placement of a robust solvent/detergent process post viral ultrafiltration of an immune gamma globulin |
| 07/05/2006 | CN1262664C Recombined procine adenovirus based on viral vaccines and vectors |
| 07/05/2006 | CN1262662C Chimeric expression promoters originating from commelina yellow mottle virus and cassava vein mosaic virus |
| 07/04/2006 | US7070997 Controlling gene expression, apoptosis in plants |
| 07/04/2006 | US7070994 genetic engineered retrovirus; from transgenic animals; drug transport |
| 07/04/2006 | US7070993 Lentiviral packaging constructs |
| 07/04/2006 | US7070992 Improved efficiency of gene expression |
| 07/04/2006 | US7070978 Expression of preferential protein in in culture; obtain cell, transfrom with vecro containg preferential protein, express vector, lyse cell, recover protein |
| 07/04/2006 | US7070930 Chimeric vectors comprising a phage packaging site and a portion derived from the genome of a eukaryotic virus |
| 07/04/2006 | US7070926 Chimaeric phages |
| 07/04/2006 | US7070789 Hybrid polypeptides as vaccine |
| 07/04/2006 | CA2228956C Cdna corresponding to the antigenome of nonsegmented negative strand rna viruses, and process for the production of such viruses encoding additional antigenically active proteins |
| 06/29/2006 | WO2006069389A1 Use of flexible bag containers for viral production |
| 06/29/2006 | WO2006068307A1 Attenuated chimeric flavivirus bearing attenuated japanese encephalitis virus gene as backbone |
| 06/29/2006 | WO2006067211A1 Rescue of influenza virus |
| 06/29/2006 | WO2005080417A3 Recombinant viruses with heterologous envelope proteins |
| 06/29/2006 | US20060141602 Packaging of positive-strand RNA virus replicon particles |
| 06/29/2006 | US20060141560 Estrogen receptor genes and utilization thereof |
| 06/29/2006 | US20060141509 Recovery of virus from cell culture using a hypertonic salt solution |
| 06/29/2006 | US20060141450 isolating a target cell, cellular organelle or virus from a sample using inter alia, non- or low-specific binding between a target cell, cellular organelle or virus with a magnetic microbead |
| 06/29/2006 | US20060140910 Recombinant adenoviral vectors and methods of use |
| 06/29/2006 | DE4445973B4 Polyvinylidenfluorid-Membran Polyvinylidene fluoride membrane |
| 06/29/2006 | CA2592495A1 Use of flexible bag containers for viral production |
| 06/29/2006 | CA2592439A1 Rescue of influenza virus |
| 06/29/2006 | CA2592005A1 Attenuated chimeric flavivirus bearing attenuated japanese encephalitis virus gene as backbone |
| 06/28/2006 | EP1674477A2 Binding polypeptides for B lymphocyte stimulator protein (BLYS) |
| 06/28/2006 | EP1673449A2 Immunogenic composition and method of developing a vaccine based on fusion protein |
| 06/28/2006 | EP1673448A2 Immunogenic compostion and method of developing a vaccine based on psoralen inactivated hiv |
| 06/28/2006 | EP1673447A1 Immunogenic composition and method of developing a vaccine based on portions of the hiv matrix protein |
| 06/28/2006 | EP1673399A2 Detecting and profiling molecular complexes |
| 06/28/2006 | EP0990041B1 Regulation of transcription in mammalian cells and viral replication by a tetracyclin repressor |
| 06/28/2006 | EP0797676B9 Recombinant adenoviral vector and methods of use |
| 06/28/2006 | EP0783585B1 DEFFECTIVE RECOMBINANT ADENOVIRUSES WITH INACTIVATED IVa2 GENE |
| 06/28/2006 | EP0757722B1 HERPES VIRUS TRANSFORMED TO EXPRESS gD IN VITRO |
| 06/28/2006 | CN1793344A Process for recovering enterovirus in sewage |
| 06/28/2006 | CN1793343A Tumourolytic anticancer recombined adenovirus with tumour target direction and idioctonia |
| 06/28/2006 | CN1793342A Process for reproducing virus of large brill hemorrhagic septicaemia by large brill fin clone |
| 06/28/2006 | CN1261564C Artificial recombined influenza virus and its application |
| 06/27/2006 | US7067310 Generation plasmid in prokaryotic cell; obtain cell, incubate with nucleotide sequences, transform cell, allow homologouus recombination to occur, recover recombinamt plasmid |
| 06/27/2006 | US7067309 Used for the transfer and expression of exogenous nucleotide sequences in a host cell or organism; gene therapy |
| 06/27/2006 | US7067245 selecting a host or replicator virus by by growing a population of viruses in a high selection pressure strain of bacteria where activity of interest confers a growth advantage; expanding the virus population, cycling the virus population through the process again |
| 06/27/2006 | CA2426283C Method for direct rescue and amplification of integrated viruses from cellular dna of tissues |
| 06/27/2006 | CA2237224C Synthetic hpv11 virus-like particles |
| 06/22/2006 | WO2006066224A2 Virulence targeted antibiotics |
| 06/22/2006 | WO2006063445A1 Recombinant foot and mouth disease vaccine |
| 06/22/2006 | US20060134778 Method of treating a malignancy in a subject via direct picornaviral-mediated oncolysis |
| 06/22/2006 | US20060134610 Chris-like virus, compositions, vaccines and uses thereof |
| 06/22/2006 | US20060134138 Recombinant influenza viruses for vaccines and gene therapy |
| 06/22/2006 | CA2592366A1 Recombinant foot and mouth disease vaccine |
| 06/22/2006 | CA2591544A1 Chimeric vectors |
| 06/21/2006 | EP1670508A2 Compositions, methods and kits relating to poxvirus subunit vaccines |
| 06/21/2006 | EP0778888B1 Antigenically-marked non-infectious retrovirus-like particles |
| 06/21/2006 | CN1791678A Improved alphavirus replicons and helper constructs |
| 06/21/2006 | CN1791675A Viral vectors expressing fusion of viral large envelope protein and protein of interest |
| 06/21/2006 | CN1260354C Method of purifying active virus |
| 06/21/2006 | CN1260353C Preparation method of polyvalent bacteriophage for treatment of bacterial infections |
| 06/20/2006 | US7064184 Use in impacting plant microbial pathogens and in enhancing plant disease resistance to microbial pathogens |
| 06/20/2006 | US7064183 Use in impacting plant microbial pathogens and in enhancing plant disease resistance to microbial pathogens |
| 06/20/2006 | US7063963 Nucleotide sequences consisiting of DNA viral open reading frames which code proteins which can be used to prepare genetic vaccines which prevent viral diseases |
| 06/20/2006 | US7063949 Methods for isolating molecular mimetics of unique Neisseria meningitidis serogroup B epitopes |
| 06/20/2006 | US7063851 Herpes viruses for immune modulation |
| 06/20/2006 | US7063835 Virus strains |
| 06/20/2006 | CA2127700C Marek's disease virus recombinant poxvirus vaccine |
| 06/15/2006 | WO2006063053A2 Methods of producing influenza vaccine compositions |
| 06/15/2006 | WO2005115448A8 Multi plasmid system for the production of influenza virus |
| 06/15/2006 | WO2004083390A3 Virulent systemic feline calicivirus |
| 06/15/2006 | US20060130180 Method of enhancing expression of exogenous polynucleotide sequences in plants |
| 06/15/2006 | US20060128019 Process for producing virus vector containing membrane protein having sialic acid-binding in envelope with the use of gram-positive bacterium origin nueraminidase |
| 06/15/2006 | US20060128011 Replication of hepatitis c virus in non-hepatic epithelial and mouse hepatic cells |
| 06/15/2006 | US20060127984 Modified Vaccinia virus Ankara for the vaccination of neonates |
| 06/15/2006 | US20060127979 Capable of generating high titer neutralizing antibody responses against at least two HPV types; prophylactic agents; diagnosis |
| 06/15/2006 | US20060127413 Recombinant mva strains as potential vaccines against p. falciparum malaria |
| 06/15/2006 | US20060127364 Insect viruses and their uses in protecting plants |
| 06/14/2006 | EP1668120A2 Method for detecting cancer cells and monitoring cancer therapy |